Department of Orthopaedic Surgery, National Taiwan University Hospital, 7 Chungsan South Road, Taipei, 10002, Taiwan.
Department of Medical Imaging and Radiological Sciences, College of Health Sciences, Central Taiwan University of Science and Technology, Taichung, Taiwan.
Int Orthop. 2020 Sep;44(9):1745-1754. doi: 10.1007/s00264-020-04569-y. Epub 2020 May 4.
Autologous minced cartilage has been used to repair cartilage defects. We have developed a biphasic cylindrical osteochondral construct for such use in human knees, and report the five year post-operative outcomes.
Ten patients with symptomatic osteochondral lesion at femoral condyles were treated by replacing pathological tissue with the osteochondral composites, each consisted a -poly-lactide-co-glycolide chondral phase and a -poly-lactide-co-glycolide/β-tricalcium phosphate osseous phase. A flat chamber between the two phases served as a reservoir to house double-minced (mechanical pulverization and enzymatical dissociation) autologous cartilage graft. The osteochondral lesion was drill-fashioned a pit of identical dimensions as the construct. Graft-laden construct was press fit to the pit. Post-operative outcome was evaluated using Knee Injury and Osteoarthritis Outcome Score (KOOS) up to five years. Regenerated tissue was sampled with arthroscopic needle biopsy for histology at one year, and imaged with magnetic resonance at one, three, and five years to evaluate the neocartilage with MOCART chart. Subchondral bone integration was evaluated with computed tomography at three and five years.
Nine patients completed the five-year follow-up. Post-operative mean KOOS, except that of the "symptom" subscale, had been significantly higher than pre-operation from one year and maintained to five years. The change of MOCRAT scores of the regenerated cartilage paralleled the change of KOOS. The osseous phase remained mineralized during the five-year period, yet did not fully integrate with the host bone.
This novel construct for chondrocyte implantation yielded promising mid-term outcome. It repaired the osteochondral lesion with hyaline-like cartilage durable for at least five years.
自体碎软骨已被用于修复软骨缺损。我们开发了一种双相柱状骨软骨构建体,用于人类膝关节,并报告了术后 5 年的结果。
10 例股骨髁骨软骨病变患者接受了该治疗,即用骨软骨复合材料替换病变组织,每个复合材料由聚乳酸-共-乙交酯软骨相和聚乳酸-共-乙交酯/β-磷酸三钙骨相组成。两个相之间的一个平坦腔室用作容纳双碎(机械粉碎和酶解)自体软骨移植物的储库。用构建体制作与病变相同尺寸的凹坑。将载有移植物的构建体压配合到凹坑中。术后 5 年采用膝关节损伤和骨关节炎评分(KOOS)评估结果。在 1 年、3 年和 5 年时,用关节镜针活检取再生组织进行组织学检查,并用磁共振成像(MRI)评估新软骨的 MOCART 图表。在 3 年和 5 年时,用计算机断层扫描(CT)评估软骨下骨整合情况。
9 例患者完成了 5 年随访。术后平均 KOOS,除“症状”亚量表外,从 1 年起均明显高于术前,并持续至 5 年。再生软骨的 MOCRAT 评分变化与 KOOS 变化平行。在 5 年期间,骨质相保持矿化,但未与宿主骨完全整合。
这种新型软骨细胞植入构建体具有良好的中期效果。它用至少 5 年耐用的透明软骨修复了骨软骨病变。